Cibc Asset Management Inc Amneal Pharmaceuticals, Inc. Transaction History

Cibc Asset Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$3.01 - $4.46 $3,208 - $4,754	-1,066 Reduced 6.82%	14,567 $46,000
Q4 2021 Feb 08, 2022	BUY	$3.95 - $5.85 $5,510 - $8,160	1,395 Added 9.8%	15,633 $75,000
Q3 2021 Nov 09, 2021	BUY	$4.31 - $5.64 $8,723 - $11,415	2,024 Added 16.57%	14,238 $76,000
Q1 2021 May 14, 2021	SELL	$4.74 - $7.38 $246 - $383	-52 Reduced 0.42%	12,214 $82,000
Q3 2020 Nov 05, 2020	BUY	$3.54 - $5.27 $1,076 - $1,602	304 Added 2.54%	12,266 $48,000
Q4 2019 Feb 14, 2020	BUY	$2.65 - $5.56 $31,699 - $66,508	11,962 New	11,962 $58,000

193

140M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.32B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Cibc Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Cibc Asset Management Inc with notifications on news.